Insiders Trades
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 06 Jan 2026 for Galectin Therapeutics INC. Read the official filing
Filing timeline
BuySaleJoel Lewis
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-0.7%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Joel Lewis: trading record in brief
This profile gathers the share dealings of Joel Lewis in Galectin Therapeutics Inc, where the filings describe the role as chief executive. Over a trading history stretching from 30 April 2021 to 2 January 2026, the count stands at 81 filings.
Purchases make up the whole of the open-market record (2 purchases, €4,590). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 71 share grants and 8 option exercises.
The record was last updated on 6 January 2026 with an option exercise in Galectin Therapeutics Inc. The last insider purchase was made public on 25 April 2024, 906 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joel Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations81 total
84,000 shares0Common StockSEC:0001133416-26-000008:0
7,829 shares@ US$2.861.0% of flowCommon StockSEC:0001133416-25-000071:0
15,680 shares@ US$2.391.7% of flowCommon StockSEC:0001133416-25-000058:0
1,867 shares@ US$2.390.2% of flowCommon StockSEC:0001133416-25-000052:0
200 shares@ US$2.390.0% of flowCommon StockSEC:0001133416-25-000048:0
1,300 shares@ US$2.390.1% of flowCommon StockSEC:0001133416-25-000044:0
14,000 shares@ US$2.391.5% of flowCommon StockSEC:0001133416-25-000038:0
56,420 shares@ US$1.573.7% of flowCommon StockSEC:0001133416-25-000029:0
56,000 shares0Common StockSEC:0001133416-24-000070:0
1,000 shares@ US$3.390.1% of flowCommon StockSEC:0001133416-24-000040:0
Canonical exit: 23 Jul 2024 (T+90)
152,584 shares@ US$1.9612.0% of flowCommon StockSEC:0001133416-24-000032:0
11,606 shares@ US$1.660.8% of flowCommon StockSEC:0001133416-24-000002:0
12,042 shares@ US$1.600.8% of flowCommon StockSEC:0001133416-23-000089:0
9,880 shares@ US$1.950.8% of flowCommon StockSEC:0001133416-23-000087:0
10,303 shares@ US$1.870.8% of flowCommon StockSEC:0001133416-23-000085:0
9,444 shares@ US$2.040.8% of flowCommon StockSEC:0001133416-23-000083:0
9,585 shares@ US$2.010.8% of flowCommon StockSEC:0001133416-23-000081:0
10,035 shares@ US$2.010.8% of flowCommon StockSEC:0001133416-23-000079:0
10,035 shares@ US$1.920.8% of flowCommon StockSEC:0001133416-23-000077:0
10,947 shares@ US$1.761.0% of flowCommon StockSEC:0001133416-23-000073:0
11,010 shares@ US$1.750.8% of flowCommon StockSEC:0001133416-23-000071:0
12,042 shares@ US$1.600.8% of flowCommon StockSEC:0001133416-23-000069:0
12,844 shares@ US$1.500.8% of flowCommon StockSEC:0001133416-23-000067:0
11,820 shares@ US$1.630.7% of flowCommon StockSEC:0001133416-23-000063:0
13,380 shares@ US$1.440.8% of flowCommon StockSEC:0001133416-23-000061:0
25 of 81 declarations
